drugset / Trial / NCT02721576

A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC

NCT02721576 ↗

Phase 4 Terminated 8 enrolled Shandong Cancer Hospital and Institute
NaSingle-groupOpen-labelTreatment

Summary

This is a perspective, multicenter,single arm, open study to evaluate the efficacy and safety of treatment with CMNa combined with concurrent chemoradiotherapy in patients with locally recurrent squamous cell esophageal carcinoma . Analyses of primary objective (ORR) will be done as defined in the protocol.

Timeline

Start
2016-07-05
Primary completion
2018-06-30
Completion
2018-07-30

Outcome

Outcome not reported

Stopped (Enrollment): “The number of enrolled cases is too small.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Glycididazole Small molecule 800 mg/m2 Intravenous